Citation Impact
Citing Papers
Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease
1998 Standout
Defining the Role of the MHC in Autoimmunity: A Review and Pooled Analysis
2008
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Susceptibility to type I diabetes: HLA-DQ and DR revisited
1996
SYFPEITHI: database for MHC ligands and peptide motifs
1999 Standout
Association of Insulin-Dependent Diabetes Mellitus and Celiac Disease: A Study Based on Serologic Markers
1998
Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis
1999
Inflammatory Bowel Disease
2009 Standout
Type 2 diabetes as an inflammatory disease
2011 Standout
Multiple sclerosis
2008 Standout
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
2009 Standout
Sources of diversity in T cell epitope discovery
2011
T cell recognition of Tn‐glycosylated peptide antigens
1996 StandoutNobel
MHC ligands and peptide motifs: first listing
1995
Thymopoiesis, Regulatory T Cells, and TCRVβ Expression in Thymoma With and Without Myasthenia Gravis, and Modulatory Effects of Steroid Therapy
2007
Celiac disease among Ashkenazi Jews from Israel
1993
HLA class II alleles associated with celiac disease susceptibility in a Southern European population
1992
Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism
1999
Differential Distribution of HLA Alleles in Two Forms of Guillain‐Barré Syndrome
1997
Acute Anterior Uveitis and HLA-B27
2005
Type 1 diabetes
2013 Standout
Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results
1995 Standout
HLA class II‐associated genetic susceptibility in multiple sclerosis: A critical evaluation
1991
The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes
2001
European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease
2011 Standout
FOXP3+ regulatory T cells in the human immune system
2010 StandoutNobel
Peptide binding characteristics of the coeliac disease-associated DQ(α1*0501, β1*0201) molecule
1996
A susceptibility region for myasthenia gravis extending into the HLA-class I sector telomeric to HLA-C
1999
HLA-DQ Locus of the Human Leukocyte Antigen Complex and Type 1 Diabetes Mellitus: A HuGE Review
2000
Are animal models useful for studying human disc disorders/degeneration?
2007 Standout
Guillain-Barré syndrome
2005 Standout
MUC1‐derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast cancer tissue
2003 StandoutNobel
Investigation of the relationship between the onset of arthritis and uveitis in genetically predisposed SKG mice
2015 StandoutNobel
Inflammatory disease in HLA‐B27 transgenic rats
1999
Generation of an MHC Class II-Restricted T Cell Epitope by Extracellular Processing of Hepatitis δ Antigen
1998 StandoutNobel
Clinical Benefit of a Gluten-Free Diet in Type 1 Diabetic Children With Screening-Detected Celiac Disease
2006 StandoutNobel
Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study.
2003 Standout
Genetic analysis of type 1 diabetes using whole genome approaches.
1995
Potential Immunocompetence of Proteolytic Fragments Produced by Proteasomes before Evolution of the Vertebrate Immune System
1997 StandoutNobel
Generation of an MHC class II-restricted T cell epitope by extracellular processing of hepatitis delta antigen.
1998 StandoutNobel
Nanomaterials and nanoparticles: Sources and toxicity
2007 Standout
Cyclodextrin Drug Carrier Systems
1998 Standout
T-cell recognition of tumor-associated carbohydrates: the nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity.
1997 StandoutNobel
Inflammatory Bowel Disease
2010 Standout
Genetic susceptibility for insulin-dependent diabetes mellitus in Caucasians revisited: the importance of diabetes registries in disclosing interactions between HLA-DQ- and insulin gene-linked risk. Belgian Diabetes Registry.
1995
Hyperglycemic Crises in Adult Patients With Diabetes
2009 Standout
Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease
2014 StandoutScienceNobel
Molecular and Immunological Significance of Chimpanzee Major Histocompatibility Complex Haplotypes for Hepatitis C Virus Immune Response and Vaccination Studies
2002 StandoutNobel
Hepatitis C Virus Envelope Glycoprotein E1 Originates in the Endoplasmic Reticulum and Requires Cytoplasmic Processing for Presentation by Class I MHC Molecules
1999 StandoutNobel
Is Juvenile Diabetes a Viral Disease?
1993
Ketosis-Prone Diabetes: Dissection of a Heterogeneous Syndrome Using an Immunogenetic and β-Cell Functional Classification, Prospective Analysis, and Clinical Outcomes
2003
Works of I Khalil being referenced
Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants. Implications for susceptibility to spondylarthropathies.
1996
A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus.
1990
Altered intrathymic T‐cell repertoire in human myasthenia gravis
1997
The role of DQ alpha–beta heterodimers in genetic susceptibility to insulin‐dependent diabetes
1993
Association of the AChRα-subunit Gene (CHRNA), DQA1*0101, and the DR3 Haplotype in Myasthenia Gravis. Evidence for a Three-gene Disease Model in a Subgroup of Patients
1997
HLA CLASS II POLYMORPHISM AND IDDM SUSCEPTIBILITY IN THE GREEK POPULATION
1993
Dose effect of cis- and trans-encoded HLA-DQ alpha beta heterodimers in IDDM susceptibility
1992
Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathy.
1996
Dose Effect of Cis- and Trans-Encoded HLA-DQαβ Heterodimers in IDDM Susceptibility
1992